Albireo Pharma, Inc. (ALBO): Price and Financial Metrics


Albireo Pharma, Inc. (ALBO)

Today's Latest Price: $24.45 USD

0.29 (-1.17%)

Updated Feb 18 8:00pm

Add ALBO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ALBO Stock Summary

  • For ALBO, its debt to operating expenses ratio is greater than that reported by only 0.37% of US equities we're observing.
  • ALBO's price/sales ratio is 86.15; that's higher than the P/S ratio of 97.47% of US stocks.
  • As for revenue growth, note that ALBO's revenue has grown -68.97% over the past 12 months; that beats the revenue growth of only 1.99% of US companies in our set.
  • Stocks that are quantitatively similar to ALBO, based on their financial statements, market capitalization, and price volatility, are XPL, HTBX, KPTI, CLSN, and PZG.
  • Visit ALBO's SEC page to see the company's official filings. To visit the company's web site, go to www.albireopharma.com.
ALBO Daily Price Range
ALBO 52-Week Price Range

ALBO Stock Price Chart More Charts


ALBO Price/Volume Stats

Current price $24.45 52-week high $38.69
Prev. close $24.74 52-week low $16.13
Day low $23.90 Volume 81,200
Day high $24.99 Avg. volume 121,756
50-day MA $23.97 Dividend yield N/A
200-day MA $25.31 Market Cap 310.20M

Albireo Pharma, Inc. (ALBO) Company Bio


Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI) disorders. The company is based in Boston, Massachusetts.


ALBO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ALBO Latest Social Stream


Loading social stream, please wait...

View Full ALBO Social Stream

ALBO Price Returns

1-mo N/A
3-mo 27.34%
6-mo 2.73%
1-year -6.25%
3-year 6.30%
5-year -41.37%
YTD -3.82%
2019 3.63%
2018 -4.18%
2017 44.39%
2016 73.82%
2015 -74.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.608 seconds.